Remove Communication Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

STAT+: U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements

STAT

Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. The oversight body noted the communications had not been subject to the regulatory approval process. A member of the U.K.

article thumbnail

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Pharmacy Times

Pharmacists can typically serve as a communication bridge between the physician and the patient. The constant communication between the provider and the pharmacist strengthens the treatment decisions made for the patient, leading to positive treatment outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Label Update for Novartis’ Leqvio to Enable Twice-Yearly Monotherapy for LDL-C Management in Adults with Hypercholesterolemia

PharmExec

August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve.

article thumbnail

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.

article thumbnail

FDA Grants Accelerated Approval to Jazz Pharmaceuticals’ Modeyso for H3 K27M-Mutant Diffuse Midline Glioma

PharmExec

Allen, PhD, chief scientific officer, Chimerix, a Jazz Pharmaceuticals Company, in the press release. "We're proud to deliver precisely the kind of transformative innovation we strive for, and we congratulate our combined Chimerix and Jazz team, and the community who worked together tirelessly to bring this treatment forward.

FDA
article thumbnail

FDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapy

Pharmaceutical Technology

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News FDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapy Modeyso is expected to be commercially available in late summer 2025. The overall response rate (ORR) was 22%, with a median duration of response of 10.3

FDA
article thumbnail

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets.